Compare, Analyse Torrent Pharma with ADCOCK INGRAM HOLDINGS LTD. - S. Africa - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

TORRENT PHARMA vs ADCOCK INGRAM (S. Africa) - Comparison Results

TORRENT PHARMA     Change

Torrent Pharmaceuticals Ltd. is the flagship company of the Torrent Group set up in 1959. Based in Ahmedabad, it was promoted by Mr U.N. Mehta initially as Trinity Laboratories Ltd. and was later renamed to its current name. The company derives its r... More

ADCOCK INGRAM (S. Africa)
   Change

Adcock Ingram is a leading South African pharmaceutical manufacturer, marketer and distributor. The company occupies 10% share of the private pharmaceutical market in South Africa with a strong presence in over-the-counter (OTC) brands. Adcock is als... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 TORRENT PHARMA   ADCOCK INGRAM
EQUITY SHARE DATA
    TORRENT PHARMA
Mar-19
ADCOCK INGRAM
Jun-14
TORRENT PHARMA/
ADCOCK INGRAM
5-Yr Chart
Click to enlarge
High Rs1,964377-   
Low Rs1,245272-   
Sales per share (Unadj.) Rs453.4112.1-  
Earnings per share (Unadj.) Rs25.8-28.3-  
Cash flow per share (Unadj.) Rs62.3-23.4-  
Dividends per share (Unadj.) Rs17.000-  
Dividend yield (eoy) %1.10-  
Book value per share (Unadj.) Rs279.288.0-  
Shares outstanding (eoy) m169.22168.78-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.52.9 122.3%   
Avg P/E ratio x62.2-11.5 -541.9%  
P/CF ratio (eoy) x25.8-13.9 -185.9%  
Price / Book Value ratio x5.73.7 155.9%  
Dividend payout %65.90-   
Avg Mkt Cap Rs m271,51354,766 495.8%   
No. of employees `00013.64.3 316.7%   
Total wages/salary Rs m14,0383,437 408.4%   
Avg. sales/employee Rs Th5,642.64,409.0 128.0%   
Avg. wages/employee Rs Th1,032.4800.7 128.9%   
Avg. net profit/employee Rs Th320.9-1,111.0 -28.9%   
INCOME DATA
Net Sales Rs m76,72818,928 405.4%  
Other income Rs m571133 430.4%   
Total revenues Rs m77,29919,061 405.5%   
Gross profit Rs m19,831-3,280 -604.6%  
Depreciation Rs m6,177817 756.1%   
Interest Rs m5,038513 982.5%   
Profit before tax Rs m9,187-4,477 -205.2%   
Minority Interest Rs m0-12 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m-3,5700-   
Tax Rs m1,254280 448.1%   
Profit after tax Rs m4,363-4,769 -91.5%  
Gross profit margin %25.8-17.3 -149.1%  
Effective tax rate %13.6-6.2 -218.4%   
Net profit margin %5.7-25.2 -22.6%  
BALANCE SHEET DATA
Current assets Rs m50,37513,863 363.4%   
Current liabilities Rs m51,6537,800 662.2%   
Net working cap to sales %-1.732.0 -5.2%  
Current ratio x1.01.8 54.9%  
Inventory Days Days92111 83.0%  
Debtors Days Days68124 55.1%  
Net fixed assets Rs m83,6488,081 1,035.1%   
Share capital Rs m84688 962.9%   
"Free" reserves Rs m46,3970-   
Net worth Rs m47,24414,856 318.0%   
Long term debt Rs m39,1295,221 749.5%   
Total assets Rs m141,20928,065 503.2%  
Interest coverage x2.8-7.7 -36.5%   
Debt to equity ratio x0.80.4 235.7%  
Sales to assets ratio x0.50.7 80.6%   
Return on assets %6.7-15.2 -43.9%  
Return on equity %9.2-32.1 -28.8%  
Return on capital %12.3-19.8 -62.3%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m16,5810-   
CASH FLOW
From Operations Rs m17,9811,616 1,112.9%  
From Investments Rs m-2,413-496 486.4%  
From Financial Activity Rs m-13,1454,738 -277.4%  
Net Cashflow Rs m2,3805,858 40.6%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ADCOCK INGRAM (S. Africa) is South Africa Rand. All data has been converted at 5.2 Rs / ZAR

Compare TORRENT PHARMA With: MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  

Compare TORRENT PHARMA With: FDC  BIOCON   WYETH  DIVIS LABORATORIES  J.B.CHEMICALS  



Today's Market

Sensex Opens 440 Points Higher; Nestle India and ACC Among Top Stocks in Focus(09:30 am)

Asian stock markets are trading on a mixed note today as investors await the release of China's latest benchmark lending rate.

Related Views On News

TORRENT PHARMA Announces Quarterly Results (2QFY21); Net Profit Up 27.0% (Quarterly Result Update)

Oct 27, 2020 | Updated on Oct 27, 2020

For the quarter ended September 2020, TORRENT PHARMA has posted a net profit of Rs 3 bn (up 27.0% YoY). Sales on the other hand came in at Rs 20 bn (up 0.6% YoY). Read on for a complete analysis of TORRENT PHARMA's quarterly results.

TORRENT PHARMA Announces Quarterly Results (1QFY21); Net Profit Up 48.6% (Quarterly Result Update)

Jul 31, 2020 | Updated on Jul 31, 2020

For the quarter ended June 2020, TORRENT PHARMA has posted a net profit of Rs 3 bn (up 48.6% YoY). Sales on the other hand came in at Rs 21 bn (up 1.7% YoY). Read on for a complete analysis of TORRENT PHARMA's quarterly results.

More Views on News

Most Popular

India: Recovery Stalled by Vaccine Games? (The Honest Truth)

Apr 13, 2021

Ajit Dayal on how India's vaccine strategy will impact the markets.

A Stock with 700% Return Potential Comes with Additional Payoffs (Profit Hunter)

Apr 15, 2021

Narayana Murthy was one of the first unicorn founders to get the backing of this entity...

11x Bankruptcy to Bluechip Stock: A Rare India Revival Story (Profit Hunter)

Apr 16, 2021

There is no stopping this 11-bagger stock from significant upside.

Why Did the Market Crash on Monday? (Fast Profits Daily)

Apr 13, 2021

In this video, I'll you what I think is the real reason behind yesterday's market crash.

A Warning About Bubbles (Fast Profits Daily)

Apr 16, 2021

Those who don't learn from financial history are doomed to lose their money.

More
-->

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

OUR TOP 5 IDEAS

Free Report: Multibagger Stock Ideas 2021
Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
Covid-19 Proof Multibagger Stocks - Download this FREE Report Now
Free Report: The Secret to Increasing Your Trading Profits Daily!
No Guessing, No Hunches, and No Missed Trends Ever! Join Us on YouTube Now.

TORRENT PHARMA SHARE PRICE


Apr 20, 2021 09:53 AM

TRACK TORRENT PHARMA

  • Track your investment in TORRENT PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON TORRENT PHARMA

TORRENT PHARMA 5-YR ANALYSIS

COMPARE TORRENT PHARMA WITH

FEATURED VIDEOS

Stability, Quality or Green Stocks for 2021?

Market Crash: Picture Abhi Baaki Hai?

It's a Great Time to Buy Gold

The Dilemma of Investing in Bharti Airtel

More Featured Videos

MARKET STATS